Pharmacokinetic Clinical Trials

1 recruiting

Pharmacokinetic Trials at a Glance

36 actively recruiting trials for pharmacokinetic are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Phase 1 with 15 trials, with the heaviest enrollment activity in Shanghai, Baltimore, and Ghent. Lead sponsors running pharmacokinetic studies include Johns Hopkins University, Children's Hospital of Fudan University, and University Hospital, Ghent.

Browse pharmacokinetic trials by phase

Treatments under study

About Pharmacokinetic Clinical Trials

Looking for clinical trials for Pharmacokinetic? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pharmacokinetic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pharmacokinetic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 36 trials

Recruiting
Phase 4

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies

AntibioticsPeriodontal DiseasesPharmacokinetics
University of Geneva, Switzerland45 enrolled1 locationNCT04669717
Recruiting
Phase 2Phase 3

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

PharmacokineticsPharmacodynamicsInsulin Aspart
Amphastar Pharmaceuticals, Inc.60 enrolled1 locationNCT07560150
Recruiting
Phase 1

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

Healthy ParticipantsPharmacokinetics
Amgen400 enrolled5 locationsNCT07422285
Recruiting
Not Applicable

A Comparison of Fisetin Kinetics in Young and Old Adults

Pharmacokinetic Study in Healthy Volunteers
University Medicine Greifswald80 enrolled1 locationNCT06796374
Recruiting
Phase 1

Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents

Pharmacokinetics After Oral Intake
Iterum Therapeutics, International Limited12 enrolled1 locationNCT07092813
Recruiting
Phase 4

Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children

Pharmacokinetics of Tafenoquine
Curtin University30 enrolled1 locationNCT07052162
Recruiting
Phase 1

Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

Pharmacokinetics
Ensysce Biosciences30 enrolled1 locationNCT06500793
Recruiting
Phase 1

Acute Effects of Oral Nicotine Pouches

Nicotine Pouch Self-AdministrationNicotine Pharmacokinetic StudyNicotine Pharmacodynamic Study
Johns Hopkins University120 enrolled1 locationNCT07128329
Recruiting

PK/PD of Caspofungin in Children Severe Infection

PharmacokineticsInfection, Fungal
Children's Hospital of Fudan University60 enrolled2 locationsNCT04961593
Recruiting

Direct Observation Study of Kratom Product Effects Among Regular Consumers

Kratom PharmacodynamicsKratom PharmacokineticsKratom
Johns Hopkins University22 enrolled1 locationNCT06089980
Recruiting
Phase 1

A Phase 1 Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

Healthy ParticipantsPharmacokinetic Study
Angitia Incorporated Limited30 enrolled1 locationNCT07361354
Recruiting

Antibiotic Dosing in Pediatric Intensive Care

PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactam+5 more
University Hospital, Ghent640 enrolled1 locationNCT02456974
Recruiting
Not Applicable

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactam+6 more
University Hospital, Ghent300 enrolled3 locationsNCT06426836
Recruiting

Medicines in Breast Milk and Estimated Infant Exposure

Medication SafetyBreastfeedingLactation+2 more
University Hospital Bispebjerg and Frederiksberg250 enrolled3 locationsNCT07346716
Recruiting
Phase 1

Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment

PharmacokineticOlverembatinib
Ascentage Pharma Group Inc.48 enrolled1 locationNCT07282093
Recruiting
Phase 1

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Healthy VolunteerSafetyPharmacokinetics+2 more
Basilea Pharmaceutica46 enrolled1 locationNCT06733675
Recruiting
Phase 1

Study of BB-025, Alone and After BB-031, in Healthy Volunteers

Healthy VolunteersPharmacokineticsPharmacodynamics
Basking Biosciences, Inc.72 enrolled1 locationNCT07202663
Recruiting
Phase 1

Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.

SafetyHealthy VolunteersTolerability+1 more
RNATICS GmbH24 enrolled1 locationNCT06752122
Recruiting

Preliminary Characterization of Commercial Kratom Extract Products

Kratom PharmacodynamicsKratom Pharmacokinetics
Johns Hopkins University16 enrolled2 locationsNCT06640569
Recruiting
Phase 1

High Potency Cannabis: Acute and Protracted Effects

PainPharmacokineticsAbuse Cannabis
University of California, Los Angeles30 enrolled1 locationNCT06859723